Traffic:
10E
10W
15N
15S
57N
57S
60E
60W
210E
210W
This Site
Web Search
powered by
YAHOO! SEARCH
Subscriber Services
|
Home Delivery
|
e-Edition
|
Alerts
|
RSS
Home
News
Ontario
Rancho Cucamonga
Pomona
Upland
Claremont
Montclair
Chino Valley
California
Crime & Public Safety
Elections
Education
S.B. County Watch
Upland Watch
I.E.: Medicare Testing Ground
Sports
Buy Event Tickets Now
Golf - Tee Times and Courses
Preps
Reign Hockey
Rancho Cucamonga Quakes
Local Colleges
USC
UCLA
Lakers
Clippers
Dodgers
Angels
Ducks
Soccer
Motor Sports
Horse Racing
Live Odds
Business
Autos
Real Estate News
Technology
Opinions
Editorial
Letters
Columnists
Blogs
LA.COM
Buy Tickets
Movies
TV
Music
Shopping & Beauty
Recreation
Neighborhood
Arts
Living
Dining
Find A Restaurant
Lottery
Horoscopes
Travel
Trevor's Travels
Health
Crossword Puzzle
Local Casinos
Foothills Magazine
Info
Subscribe For Home Delivery
Contact Us
RSS
Podcast
Subscriber Services
Place An Ad
NIE
Classified
Place an Ad
Homes
Jobs
Auto
Search autos
Buy/Sell a car
Research/Financing a car
Find a dealer
Shopping
This week's ads
Obits
Directories
Local Business
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mei Pharma Inc
(NQ:
MEIP
)
3.000
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
3.000
Bid (Size)
2.870 (2)
Ask (Size)
3.120 (19)
Prev. Close
3.000
Today's Range
3.000 - 3.000
52wk Range
2.729 - 7.873
Shares Outstanding
6,662,857
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives
August 12, 2024
From
MEI Pharma, Inc.
Via
Business Wire
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 22, 2024
Via
Benzinga
Performance
YTD
-50.08%
-50.08%
1 Month
-3.23%
-3.23%
3 Month
+6.38%
+6.38%
6 Month
-19.35%
-19.35%
1 Year
-42.75%
-42.75%
More News
Read More
MEI Pharma to Consider Strategic Alternatives
July 22, 2024
From
MEI Pharma, Inc.
Via
Business Wire
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 16, 2024
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
May 14, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
MEIP Stock Earnings: MEI Pharma Beats EPS for Q3 2024
May 09, 2024
Via
InvestorPlace
MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights
May 09, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients
April 11, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia
March 26, 2024
From
MEI Pharma, Inc.
Via
Business Wire
5 Value Stocks In The Healthcare Sector
February 19, 2024
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
February 15, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights
February 13, 2024
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024
January 16, 2024
From
MEI Pharma, Inc.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
January 08, 2024
Via
Benzinga
Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)
December 14, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023
December 11, 2023
From
MEI Pharma, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
November 16, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 16, 2023
Via
Benzinga
MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights
November 09, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma to Present at the Stifel 2023 Healthcare Conference
November 08, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock
November 06, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023
November 02, 2023
From
MEI Pharma, Inc.
Via
Business Wire
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital
November 01, 2023
From
MEI Pharma, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Privacy Policy
|
Terms of Use
|
MNG Corporate Site Map
|
Copyright